These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9806153)
1. The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor. Gill JH; Brickell P; Dive C; Roberts RA Carcinogenesis; 1998 Oct; 19(10):1743-7. PubMed ID: 9806153 [TBL] [Abstract][Full Text] [Related]
2. The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas. Gill JH; James NH; Roberts RA; Dive C Carcinogenesis; 1998 Feb; 19(2):299-304. PubMed ID: 9498280 [TBL] [Abstract][Full Text] [Related]
3. G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent non-genotoxic hepatocarcinogen nafenopin. Chevalier S; Roberts RA Carcinogenesis; 1999 Jul; 20(7):1209-13. PubMed ID: 10383891 [TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro. Hasmall SC; James NH; Soames AR; Roberts RA Arch Toxicol; 1998 Dec; 72(12):777-83. PubMed ID: 9950074 [TBL] [Abstract][Full Text] [Related]
5. Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin. Strange J; Roberts RA Mutat Res; 1996 Nov; 372(1):107-13. PubMed ID: 9003537 [TBL] [Abstract][Full Text] [Related]
6. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Roberts RA; Soames AR; Gill JH; James NH; Wheeldon EB Carcinogenesis; 1995 Aug; 16(8):1693-8. PubMed ID: 7634391 [TBL] [Abstract][Full Text] [Related]
7. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin. West DA; James NH; Cosulich SC; Holden PR; Brindle R; Rolfe M; Roberts RA Hepatology; 1999 Dec; 30(6):1417-24. PubMed ID: 10573520 [TBL] [Abstract][Full Text] [Related]
8. The rodent nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin inhibits intercellular communication in rat but not guinea-pig hepatocytes, perturbing S-phase but not apoptosis. Elcock FJ; Chipman JK; Roberts RA Arch Toxicol; 1998 Jun; 72(7):439-44. PubMed ID: 9708883 [TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes. James NH; Roberts RA Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222 [TBL] [Abstract][Full Text] [Related]
10. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. Bayly AC; Roberts RA; Dive C J Cell Biol; 1994 Apr; 125(1):197-203. PubMed ID: 8138571 [TBL] [Abstract][Full Text] [Related]
11. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro. Hasmall SC; West DA; Olsen K; Roberts RA Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804 [TBL] [Abstract][Full Text] [Related]
12. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. James NH; Roberts RA Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418 [TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin. Holden PR; Hasmall SC; James NH; West DR; Brindle RD; Gonzalez FJ; Peters JM; Roberts RA Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):29-39. PubMed ID: 10726969 [TBL] [Abstract][Full Text] [Related]
14. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha). Hasmall S; James N; Hedley K; Olsen K; Roberts R Arch Toxicol; 2001 Aug; 75(6):357-61. PubMed ID: 11570693 [TBL] [Abstract][Full Text] [Related]
15. Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators. Cosulich S; James N; Roberts R Carcinogenesis; 2000 Apr; 21(4):579-84. PubMed ID: 10753189 [TBL] [Abstract][Full Text] [Related]
16. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha. Hasmall SC; James NH; Macdonald N; Gonzalez FJ; Peters JM; Roberts RA Mutat Res; 2000 Mar; 448(2):193-200. PubMed ID: 10725472 [TBL] [Abstract][Full Text] [Related]
17. Nafenopin causes protein kinase C-mediated serine phosphorylation and loss of function of connexin 32 protein in rat hepatocytes without aberrant expression or localization. Elcock FJ; Deag E; Roberts RA; Chipman JK Toxicol Sci; 2000 Jul; 56(1):86-94. PubMed ID: 10869456 [TBL] [Abstract][Full Text] [Related]
18. A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin. Cosulich SC; James NH; Needham MR; Newham PP; Bundell KR; Roberts RA Carcinogenesis; 2000 Sep; 21(9):1757-60. PubMed ID: 10964109 [TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferator nafenopin. Chevalier S; Macdonald N; Tonge R; Rayner S; Rowlinson R; Shaw J; Young J; Davison M; Roberts RA Eur J Biochem; 2000 Aug; 267(15):4624-34. PubMed ID: 10903494 [TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Rolfe M; James NH; Roberts RA Carcinogenesis; 1997 Nov; 18(11):2277-80. PubMed ID: 9395232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]